tiprankstipranks
Advertisement
Advertisement
Curis Reaffirmed at Buy as Analyst Maintains $5 Price Target on Emavusertib Clinical Catalysts in CLL and PCNSL
PremiumRatingsCuris Reaffirmed at Buy as Analyst Maintains $5 Price Target on Emavusertib Clinical Catalysts in CLL and PCNSL
19d ago
Curis Buy Rating Reiterated as Analyst Highlights Dual-Blockade Progress and Clinical Catalysts; $17 Price Target Maintained
Premium
Ratings
Curis Buy Rating Reiterated as Analyst Highlights Dual-Blockade Progress and Clinical Catalysts; $17 Price Target Maintained
19d ago
Curis reports Q1 EPS ($1.25), consensus (29c)
Premium
The Fly
Curis reports Q1 EPS ($1.25), consensus (29c)
19d ago
Why Is Vanguard Total Stock Market (VTI) ETF Up Today, 5/7/26?
PremiumMarket NewsWhy Is Vanguard Total Stock Market (VTI) ETF Up Today, 5/7/26?
25d ago
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/6/26?
Premium
Market News
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/6/26?
26d ago
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/5/26?
Premium
Market News
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/5/26?
27d ago
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/29/26?
PremiumMarket NewsWhy Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/29/26?
1M ago
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/28/26?
Premium
Market News
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/28/26?
1M ago
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/27/26?
Premium
Market News
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/27/26?
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100